Clinical Trials in New York

Showing 8121-8140 of 22,668 trials

Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor

NCT05361655

A retrospective study of de-identified (to preserve patient privacy) patient information from the Flatiron Health Analytic Database to compare effectiveness (i.e., overall survival) of first line palbociclib + aromatase inhibitor (AI) versus AI alone treatment in postmenopausal women or men with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2-) metastatic breast cancer (MBC) in the United States clinical practices.

Metastatic Breast Cancer

Pfizer2,888 participantsStarted Sep 2021

New York, New York, United States

TERMINATEDPhase 3< 1 mile

A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

NCT04688931

This global, randomized, controlled, open-label Phase 3 study was designed to assess the long-term efficacy and safety of UGN-102 (mitomycin) for intravesical solution with or without (±) transurethral resection of bladder tumors (TURBT) versus TURBT alone for the treatment of patients with low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder

UroGen Pharma Ltd.282 participantsStarted Feb 2021

Tucson, Arizona, United States • Loma Linda, California, United States • Los Angeles, California, United States +136 more locations

Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor

A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Find Trials by Condition in New York

Restoring Energy With Sub-symptom Threshold Optimized Rehabilitation Exercise for Long COVID

Perampanel Titration and Cognitive Effects

Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer

Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Hip Hop Stroke: Statewide Dissemination of a School-based Public Stroke Education Intervention

Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease

An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease

Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)

Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B